Organization · Venture Capital
GT Healthcare Capital Partners
GT Healthcare Capital Partners is a life science-focused private equity and venture capital firm that specializes in healthcare investments, particularly in medical devices and pharmaceuticals, with a strong emphasis on cross-border opportunities in Asia.
Overview
What GT Healthcare Capital Partners does
What GT Healthcare Capital Partners is
GT Healthcare Capital Partners is a life science-focused private equity and venture capital firm that specializes in healthcare investments, particularly in medical devices and pharmaceuticals, with a strong emphasis on cross-border opportunities in Asia.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find GT Healthcare Capital Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
GT Healthcare Capital Partners as a funder
Investment thesis
GT Healthcare Capital Partners focuses on early-stage investments in the healthcare sector, particularly in medical devices and pharmaceuticals, aiming to enhance healthcare delivery and patient outcomes.
Focus narrative
The firm primarily invests in the healthcare sector, with a strong emphasis on medical devices and pharmaceutical innovations. GT Healthcare Capital Partners targets early-stage companies that are poised to make significant impacts in healthcare, focusing on technologies that enhance patient care and outcomes.
Value beyond capital
GT Healthcare Capital Partners adds value to its portfolio companies through strategic guidance, leveraging its expertise in healthcare and access to cross-border markets, particularly in Greater China. The firm actively supports its companies in navigating regulatory landscapes and expanding their market reach.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B
- Sectors
- Healthcare · Biotech · Medical Devices · AI
- Regions
- Asia · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Oxford Nanopore Technologies
Portfolio context
Notable portfolio companies include: Oxford Nanopore Technologies: Developer of the MinION, a portable DNA sequencing device, which has expanded into Asian markets with GT Healthcare's support. Potrero Medical: Known for its predictive algorithm for acute kidney injury, which has received FDA breakthrough device designation. Moon Surgical: Specializes in human-robot interaction for surgical procedures, recently raising $31 million in Series A funding. GT Apeiron Therapeutics: Launched with $27M to develop AI-driven investigational medicines, focusing on oncology drug discovery in collaboration with Exscientia.
Common questions
What to know about GT Healthcare Capital Partners
Upseed classifies GT Healthcare Capital Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.